Found: 21
Select item for more details and to access through your institution.
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01566-1
- By:
- Publication type:
- Article
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1332939
- By:
- Publication type:
- Article
Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 2, p. 175, doi. 10.20892/j.issn.2095-3941.2023.0248
- By:
- Publication type:
- Article
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01626-4
- By:
- Publication type:
- Article
AI-powered discovery of a novel p53-Y220C reactivator.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1229696
- By:
- Publication type:
- Article
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00706-x
- By:
- Publication type:
- Article
Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2151, doi. 10.1007/s00262-023-03407-5
- By:
- Publication type:
- Article
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8 + T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184512
- By:
- Publication type:
- Article
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2861, doi. 10.3390/cancers14122861
- By:
- Publication type:
- Article
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2952, doi. 10.3390/cancers14122952
- By:
- Publication type:
- Article
Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 875, doi. 10.1111/cas.15261
- By:
- Publication type:
- Article
Co‐immunization with L‐Myc enhances CD8<sup>+</sup> or CD103<sup>+</sup> DCs mediated tumor‐specific multi‐functional CD8<sup>+</sup> T cell responses.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3469, doi. 10.1111/cas.15044
- By:
- Publication type:
- Article
Resveratrol pretreatment mitigates LPS-induced acute lung injury by regulating conventional dendritic cells’ maturation and function.
- Published in:
- Open Life Sciences, 2021, v. 16, n. 1, p. 1064, doi. 10.1515/biol-2021-0110
- By:
- Publication type:
- Article
Post-translational modifications of EZH2 in cancer.
- Published in:
- Cell & Bioscience, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13578-020-00505-0
- By:
- Publication type:
- Article
gB co‐immunization with GP96 enhances pulmonary‐resident CD8 T cells and exerts a long‐term defence against MCMV pneumonitis.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 24, p. 14426, doi. 10.1111/jcmm.16065
- By:
- Publication type:
- Article
Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 18, p. 10744, doi. 10.1111/jcmm.15697
- By:
- Publication type:
- Article
The optimization system for preparation of TG1 competent cells and electrotransformation.
- Published in:
- MicrobiologyOpen, 2020, v. 9, n. 7, p. 1, doi. 10.1002/mbo3.1043
- By:
- Publication type:
- Article
The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41419-020-2225-6
- By:
- Publication type:
- Article
ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 5, p. 3520, doi. 10.1111/jcmm.14251
- By:
- Publication type:
- Article
H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 11, p. 5670, doi. 10.1111/jcmm.13842
- By:
- Publication type:
- Article
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.
- Published in:
- Journal of Immunology Research, 2017, p. 1, doi. 10.1155/2017/6915912
- By:
- Publication type:
- Article